A recent study titled "Effect of Cannabis and Subproducts on Anthropometric Measures: A Systematic Review and Meta-Analysis" published in the International Journal of Obesity, explored the impact of cannabis and its derivatives on anthropometric measures in obese adults.

The study involved 27 selected trials comprising 4,394 participants from various countries, including France, the UK, the US, Canada, Argentina and others.

As first reported by News Medical Life Sciences, cannabis derivatives, such as rimonabant, hemp oil, cannabidiol, caryophyllene, and tetrahydrocannabinol (THC), demonstrated promise in reducing body weight, body mass …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.